Christian Meisel

Author PubWeight™ 78.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003 3.89
2 Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 2010 3.60
3 Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007 2.76
4 Terminally differentiated CD8⁺ T cells negatively affect bone regeneration in humans. Sci Transl Med 2013 2.43
5 Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008 2.39
6 Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers. Pharmacogenetics 2002 1.85
7 Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2003 1.76
8 Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 2005 1.74
9 Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther 2002 1.58
10 Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 2007 1.42
11 Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clin Pharmacol Ther 2002 1.42
12 Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006 1.39
13 Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplant Res 2013 1.27
14 No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One 2010 1.25
15 Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care 2009 1.16
16 Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation. Proc Natl Acad Sci U S A 2011 1.15
17 Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med (Berl) 2008 1.14
18 Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. J Cereb Blood Flow Metab 2012 1.11
19 Immune responses after acute ischemic stroke or myocardial infarction. Int J Cardiol 2010 1.08
20 Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol 2007 1.02
21 Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis 2011 1.01
22 Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples. Transplantation 2009 1.01
23 Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets. Eur J Immunol 2010 1.01
24 Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients. Arthritis Res Ther 2009 1.01
25 MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males. Br J Clin Pharmacol 2002 0.99
26 Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers. Clin Pharmacokinet 2004 0.99
27 Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry B Clin Cytom 2003 0.99
28 Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 2004 0.99
29 CCN1: a novel inflammation-regulated biphasic immune cell migration modulator. Cell Mol Life Sci 2012 0.98
30 Immunodepression after aneurysmal subarachnoid hemorrhage. Stroke 2010 0.96
31 Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization. J Immunol 2003 0.95
32 Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites. Pharmacogenetics 2003 0.94
33 Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 2003 0.93
34 Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways. J Cell Sci 2011 0.92
35 Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers. Clin Pharmacol Ther 2003 0.90
36 Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH. Exp Neurol 2007 0.89
37 Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology 2011 0.89
38 Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells. Arthritis Rheum 2003 0.88
39 Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. Clin Pharmacol Ther 2002 0.88
40 Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers. Eur J Clin Pharmacol 2006 0.87
41 The SCIentinel study--prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)--study protocol and interim feasibility data. BMC Neurol 2013 0.86
42 Mouse strains differ in their susceptibility to poststroke infections. Neuroimmunomodulation 2006 0.86
43 Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies. Crit Care 2010 0.85
44 Elevation of CD4+ differentiated memory T cells is associated with acute cellular and antibody-mediated rejection after liver transplantation. Transplantation 2013 0.85
45 Predicting post-stroke infections and outcome with blood-based immune and stress markers. Cerebrovasc Dis 2012 0.85
46 Differential affection of intestinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodulation 2009 0.85
47 Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach. J Cereb Blood Flow Metab 2013 0.84
48 CD31+ naïve Th cells are stable during six months following kidney transplantation: implications for post-transplant thymic function. Am J Transplant 2005 0.84
49 Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. Scand J Infect Dis 2010 0.83
50 Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. Br J Clin Pharmacol 2003 0.82
51 Microglial activation milieu controls regulatory T cell responses. J Immunol 2013 0.81
52 Pharmacogenetics-based new therapeutic concepts. Drug Metab Rev 2004 0.81
53 Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers. Pharmacogenetics 2004 0.81
54 Polymorphisms of adrenergic receptors and the risk of heart failure. N Engl J Med 2003 0.81
55 Differential expression and function of α-mannosidase I in stimulated naive and memory CD4+ T cells. J Immunother 2011 0.80
56 Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice. Am J Respir Cell Mol Biol 2014 0.80
57 Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency. Hum Immunol 2009 0.80
58 Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1. Exp Neurol 2008 0.80
59 Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis. J Perinat Med 2015 0.80
60 STRoke Adverse outcome is associated WIth NoSocomial Infections (STRAWINSKI): procalcitonin ultrasensitive-guided antibacterial therapy in severe ischaemic stroke patients - rationale and protocol for a randomized controlled trial. Int J Stroke 2012 0.80
61 Point-of-care testing for interleukin-6 in cerebro spinal fluid (CSF) after subarachnoid haemorrhage. Med Sci Monit 2008 0.79
62 Expression of tolerance associated gene-1, a mitochondrial protein inhibiting T cell activation, can be used to predict response to immune modulating therapies. J Immunol 2009 0.79
63 MLL becomes functional through intra-molecular interaction not by proteolytic processing. PLoS One 2013 0.79
64 Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurements. Clin Biochem 2008 0.79
65 Infectious and immunologic phenotype of MECP2 duplication syndrome. J Clin Immunol 2015 0.78
66 Discrimination of T-cell subsets and T-cell receptor repertoire distribution. Immunol Res 2014 0.78
67 Dysfunction of alveolar macrophages after cardiac surgery and postoperative pneumonia?--An observational study. Crit Care 2013 0.78
68 Systematic analysis of sequence variability of the endothelin-1 gene: a prerequisite for association studies. Genet Test 2006 0.77
69 IFN-gamma regulation in anti-CD4 antibody-induced T cell unresponsiveness. J Am Soc Nephrol 2004 0.76
70 Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients. Transpl Immunol 2013 0.75
71 Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences. J Mol Med (Berl) 2003 0.75
72 High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression. Mediators Inflamm 2010 0.75
73 Inadequate cytoplasmatic calcium signals in alveolar macrophages after cardiac surgery. Inflamm Res 2010 0.75
74 Identification of twelve polymorphisms in the endothelin-1 gene by use of fluorescently labeled oligonucleotides and PCR with restriction fragment polymorphism analysis. Clin Chem 2004 0.75
75 Genetic investigations of Saethre-Chotzen syndrome presenting with renal cell carcinoma. Cancer Genet Cytogenet 2006 0.75
76 Antibiotic Prophylaxis, Immunoglobulin Substitution and Supportive Measures Prevent Infections in MECP2 Duplication Syndrome. Pediatr Infect Dis J 2017 0.75
77 Interpreting Immune Mediator Dysbalance in Sepsis. Crit Care Med 2017 0.75
78 Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies. J Clin Immunol 2015 0.75